Corrigendum to: LTBK-01. Updates On The Phase Ii And Re-treatment Study Of AZD6244 (Selumetinib) For Children With Recurrent Or Refractory Pediatric Low Grade Glioma: A Pediatric Brain Tumor Consortium (PBTC) Study. Neuro-oncology Fangusaro, J. R., Onar-Thomas, A., Poussaint, T. Y., Wu, S., Ligon, A. H., Lindeman, N. I., Banerjee, A., Packer, R., Kilburn, L. B., Pollack, I. F., Qaddoumi, I. A., Fisher, P. G., Dhall, G., Baxter, P. A., Kreissman, S. G., Doyle, L. A., Smith, M. A., Fouladi, M., Dunkel, I. J. 2022

View details for DOI 10.1093/neuonc/noac029

View details for PubMedID 35307742